HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ileal mucosal mononuclear cells in patients with seronegative spondylarthropathy.

Abstract
In order to study local immunoregulatory mechanisms in patients with seronegative spondylarthropathy and histological evidence of asymptomatic intestinal inflammation, we determined mononuclear cells in distal ileal mucosa with an indirect immunoperoxidase technique using a panel of monoclonal antibodies. The number of intraepithelial lymphocytes in inflamed mucosa was not significantly increased. They carried mainly the suppressor-cytotoxic CD8 marker (greater than 80%), less frequently the helper T cell marker CD4 and lacked the pan T epitope CD3 in greater than 50%. There were no intraepithelial B cells or natural killer cells. The lamina propria lymphocytes were T and B cells, the former being more numerous. Helper T cells were more frequent than suppressor-cytotoxic T cells. There were no alterations in the proportion of T cells in inflamed mucosa. Natural killer cells were scarce. They occurred in small numbers in a minority of cases with gut inflammation and spondylarthropathy and rarely in inflammatory bowel disease. It is concluded that although there is an increase of lamina propria monocytes, there is no immunoregulatory imbalance in the ileal mucosa of patients with seronegative spondylarthropathy.
AuthorsC Cuvelier, A M Dierick, H Mielants, M De Vos, E Veys, H Roels
JournalClinical and experimental rheumatology (Clin Exp Rheumatol) 1990 Mar-Apr Vol. 8 Issue 2 Pg. 137-43 ISSN: 0392-856X [Print] Italy
PMID2338010 (Publication Type: Journal Article)
Topics
  • Adolescent
  • Adult
  • Aged
  • Arthritis (complications)
  • Female
  • Humans
  • Ileum (pathology)
  • Intestinal Mucosa (pathology)
  • Joint Diseases (complications)
  • Killer Cells, Natural (pathology)
  • Leukocyte Count
  • Leukocytes, Mononuclear (pathology)
  • Lymphocytes (pathology)
  • Male
  • Middle Aged
  • Spondylitis, Ankylosing (complications, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: